Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Assessment of Low-dose ASA Discontinuation Risk Associated With Concomitant PPI Use During the First Year of ASA Therapy for Secondary Prevention

NCT01888575 is registered in ClinicalTrials.gov with AstraZeneca as lead sponsor.

NCT NCT01888575
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01888575 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Assessment of Low-dose ASA Discontinuation Risk Associated With Concomitant PPI Use During the First Year of ASA Therapy for Secondary Prevention
Lead sponsor
AstraZeneca
Phase
Observational
Overall status
Completed
Start date
September 30, 2012
Completion date
June 30, 2013
Enrollment
35,604 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

cardiovascular prevention